Is it time now to stop searching for other tumor markers for HCC apart from alpha-fetoprotein? | ||||
| African Journal of Gastroenterology and Hepatology | ||||
| Article 3, Volume 4, Issue 1, July 2021, Page 26-28 PDF (298.88 K) | ||||
| DOI: 10.52378/fkha1952 | ||||
 View on SCiNiTO | ||||
| Author | ||||
Ahmed Elsayed Mohamed Esmaiel
| ||||
| A resident of Hepatology and Gastroenterology, Kafr Elsheikh Liver Research Center | ||||
| Abstract | ||||
| Despite the uncountable amount of tumor markers, no one shows superiority over alpha-fetoprotein. Also, liquid biopsies are used to diagnose HCC but are still under extensive research. | ||||
| Keywords | ||||
| hepatocellular carcinoma; alpha-fetoprotein; tumor markers | ||||
|
Supplementary Files
|
||||
|
Statistics Article View: 287 PDF Download: 216 |
||||
